TeSlaa, Tara http://orcid.org/0000-0002-0504-0998
Ralser, Markus http://orcid.org/0000-0001-9535-7413
Fan, Jing http://orcid.org/0000-0002-5326-5358
Rabinowitz, Joshua D. http://orcid.org/0000-0002-1247-4727
Funding for this research was provided by:
Ludwig Institute for Cancer Research
Article History
Received: 3 August 2022
Accepted: 12 July 2023
First Online: 23 August 2023
Competing interests
: J.D.R. is an advisor and stockholder in Colorado Research Partners, LEAF Pharmaceuticals, Empress Therapeutics and Bantam Pharmaceutical; a paid consultant of Pfizer and Third Rock Ventures; a founder, director and stockholder of Farber Partners, Raze Therapeutics and Sofro Pharmaceuticals; a cofounder and stockholder in Marea Therapeutics; and a director of the Princeton University–PKU Shenzhen collaboration. All other authors declare no competing interests.